Request for a Preliminary Ruling by Federal Court of Justice on the Prohibition of Advertising for Remote Medical Treatments under Section 9 HWG
31 March 2026
Daniel Tietjen is member of the Practice Area Patents Technology & Life Sciences and the Life Sciences & Healthcare Industry Group. His focus is on litigation and legal advice to national and international companies, particularly in all areas of pharmaceutical law, medical device law, unfair competition law and intellectual property law including trademark law.
Daniel's news & insights
Life sciences & healthcare
Click here to find out more
Reform of the Veterinary Medicines Act
13 October 2025
Briefing
Synapse - Europe's approach to supply chain issues for medicines and medical devices
Click here to find out more
Comparison of national measures to protect the supply of medicines and medical devices
Our international team has developed a practical guide that allows users to navigate different European jurisdictions, identifying medicines subject to supply restrictions, and understand manufacturers' obligations during shortages or product withdrawals.
1 October 2025
5 of 5 Insights
